Who invested in Amphista Therapeutics?
Amphista Therapeutics's investors include Eli Lilly, Forbion Capital Partners, Novartis and European Investment Fund.
United Kingdom · Series B startup
5 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 4 months ago
Funding summaryUpdated 26 Oct 2026
$154Mraised across 5 rounds since 2021, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
Source recorded
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Amphista Therapeutics's investors include Eli Lilly, Forbion Capital Partners, Novartis and European Investment Fund.
Amphista Therapeutics has raised $154M across 5 rounds since 2021. One round did not disclose an amount, so the total is a floor.
Amphista Therapeutics's most recent round, $97M, was in Jun 2026.
Its most recent round, $97M in Jun 2026, is also its largest on record.
Amphista Therapeutics's first round on record, in Dec 2022, was backed by Eli Lilly, Forbion Capital Partners and Novartis and 1 others.
Amphista Therapeutics's latest named round is a Series B, in Oct 2025.
Amphista Therapeutics is based in the United Kingdom.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.